Clostridium difficile Colitis: A Review

@article{Moudgal2012ClostridiumDC,
  title={Clostridium difficile Colitis: A Review},
  author={Varsha V Moudgal and Jack D. Sobel},
  journal={Hospital Practice},
  year={2012},
  volume={40},
  pages={139 - 148}
}
Abstract Clostridium difficile has become an increasingly important nosocomial pathogen and is one of the most common causes of hospital-acquired diarrhea. The incidence of C difficile infection (CDI) is increasing worldwide. Overuse of antibiotics is felt to be a major contributing factor leading to the increased incidence of CDI. The clinical manifestations of CDI vary from a mild form of the disease to fulminant diarrhea, leading to significant patient morbidity and mortality. The increasing… 
Tigecycline for the Treatment of Severe and Severe Complicated Clostridium difficile Infection
TLDR
Tigecycline appears to be a reasonable addition to the therapeutic regimen in the treatment of severe or complicated CDI, including cases that are refractory to standard therapy.
Clinical differences in Clostridium difficile infection based on age: A multicenter study
TLDR
Although advancing age is an important risk factor for CDI, the clinical features of younger patients are similar to those of the older patient population, and more patients recovered from CDI without specific antibiotic treatment in the younger group than in the older group.
The Analysis of Risk Factors and Clinical-Demographic Characteristics of Patients with Clostridium Dificille Infection as Well as The Outcome of Their Treatment
TLDR
The clinical and demographic characteristics of patients with diagnosed Clostridium difficile infection, the most prevalent characteristics (age, antibiotic therapy, PPI and H2 blocker use), were present in this study as well.
Role of the hospital environment in disease transmission, with a focus on Clostridium difficile
TLDR
Key measures to prevent C. difficile transmission and infection include antibiotic stewardship (minimising antibiotic use), placing patients with CDI on contact precautions, and proper cleaning and disinfection of the surfaces in hospital rooms daily and at discharge using a sporicidal disinfectant or a ‘no-touch' method.
Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic.
TLDR
It is postulate that the plethora of effects of C. difficile and the vast amount of data on the role of commensal gut residents and probiotics point towards a multistrain mixture of probiotics to reduce CDI, but also to limit (nosocomial) transmission and/or endogenous reinfection.
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
  • J. van Prehn, E. Reigadas, E. Kuijper
  • Medicine, Biology
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2021
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
  • S. Debast, M. Bauer, E. Kuijper
  • Medicine, Biology
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2014
TLDR
An update and review on the comparative effectiveness of the currently available treatment modalities of CDI is given, thereby providing evidence-based recommendations on this issue.
...
...

References

SHOWING 1-10 OF 83 REFERENCES
Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis
TLDR
A prospective study of hospitalized adult patients to define readily available clinical and laboratory parameters that can help predict the presence of C. difficile toxin and assess the effectiveness of laboratory tests for C.difficile disease.
Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem.
  • D. Gerding
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2004
TLDR
The saga of CDAD risk and antimicrobial use has been extended to the fluoroquinolone class, as shown by Gaynes et al.
Lack of value of repeat stool testing for Clostridium difficile toxin.
Impact of Clostridium difficile infection in patients with ulcerative colitis.
A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.
TLDR
A strain of C. difficile that was resistant to fluoroquinolones and had binary toxin and a partial deletion of the tcdC gene was responsible for this outbreak ofC.difficile-associated diarrhea.
Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study.
TLDR
Cases diagnosed by the presence of cytotoxin or pseudomembranes were found to have been hospitalized longer at diarrhea onset, to have had more antecedent infections, and to have received clindamycin, multiple antimicrobials, and therapeutic antimicro bials more often than controls, but controls received prophylactic antimicroBials more frequently than cases.
Management of Clostridium difficile infection: thinking inside and outside the box.
  • D. Gerding, Stuart Johnson
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
TLDR
Optimism is provided that more-effective management of CDI is forthcoming following recent advances in understanding and new agent under development, fidaxomicin, which appears to be equal in efficacy to vancomycin but with less risk of subsequent CDI recurrences.
Fidaxomicin versus vancomycin for Clostridium difficile infection.
TLDR
Fidaxomicin was associated with a significantly lower rate of recurrence of C. difficile infection associated with non–North American Pulsed Field type 1 strains and the adverse-event profile was similar for the two therapies.
Antibiotic-Associated Diarrhea
TLDR
Clinicians should monitor for this potential adverse effect caused by antibiotics, which can be a reason for a patient to become non-compliant or receive incomplete treatment.
...
...